메뉴 건너뛰기




Volumn 15, Issue 10, 2014, Pages 988-1000

Na+/K+ ATPase inhibitors in cancer

Author keywords

Bufadienolides; Bufalin; Cancer therapy; Cardenolides; Cardiotonic steroids; Digoxin; Istaroxime; Na+ K+ ATPase; Sodium potassium ATPase; Steroidal Na+ K+ ATPase inhibitors

Indexed keywords

2 OXOVORUSCHARIN; 3 R POD; 3 [(R) 3 PYRROLIDINYL]OXIME DERIVATIVE 3; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; BUFALIN; CARBOPLATIN; CARDIAC GLYCOSIDE; CASPASE 3; CISPLATIN; COUMESTAN; DACARBAZINE; DIGITOXIN; DIGOXIN; DOCETAXEL; ERLOTINIB; GOSSYPOL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERFERON; INTERLEUKIN 2; ISTAROXIME; LAPATINIB; MB 7; OLEANDRIN; OUABAIN; OXIME DERIVATIVE; PROTEIN KINASE B; UNBS 1450; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR;

EID: 84913574059     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450115666140908125025     Document Type: Article
Times cited : (80)

References (123)
  • 2
    • 0021323238 scopus 로고
    • The basic mechanism of inotropic action of digitalis glycosides
    • Smith TW. The basic mechanism of inotropic action of digitalis glycosides. J Pharmacol 1984; 15 Suppl 1: 35-51.
    • (1984) J Pharmacol , vol.15 , pp. 35-51
    • Smith, T.W.1
  • 3
  • 4
    • 0038621773 scopus 로고    scopus 로고
    • Structure and mechanism of Na, K-ATPase: Functional sites and their interactions
    • Jorgensen PL, Hakansson KO, Karlish SJ. Structure and mechanism of Na, K-ATPase: functional sites and their interactions. Annu Rev Physiol 2003; 65: 817-49.
    • (2003) Annu Rev Physiol , vol.65 , pp. 817-849
    • Jorgensen, P.L.1    Hakansson, K.O.2    Karlish, S.J.3
  • 5
    • 0034773778 scopus 로고    scopus 로고
    • The functional role of beta subunits in oligomeric Ptype ATPases
    • Geering K. The functional role of beta subunits in oligomeric Ptype ATPases. J Bioenerg Biomembr 2001; 33: 425-38.
    • (2001) J Bioenerg Biomembr , vol.33 , pp. 425-438
    • Geering, K.1
  • 6
  • 7
    • 0033550055 scopus 로고    scopus 로고
    • Functional characterization of a testes-specific alpha-subunit isoform of the sodium/potassium adenosinetriphosphatase
    • Blanco G, Melton RJ, Sánchez G, Mercer RW. Functional characterization of a testes-specific alpha-subunit isoform of the sodium/potassium adenosinetriphosphatase. Biochemistry 1999; 38: 13661-9.
    • (1999) Biochemistry , vol.38 , pp. 13661-13669
    • Blanco, G.1    Melton, R.J.2    Sánchez, G.3    Mercer, R.W.4
  • 8
    • 28644447041 scopus 로고    scopus 로고
    • Na, K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation
    • Blanco G. Na, K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation. Semin Nephrol 2005; 25: 292-303.
    • (2005) Semin Nephrol , vol.25 , pp. 292-303
    • Blanco, G.1
  • 9
    • 0033898109 scopus 로고    scopus 로고
    • Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions
    • Mobasheri A, Avila J, Cózar-Castellano I, et al. Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci Rep 2000; 20: 51-91.
    • (2000) Biosci Rep , vol.20 , pp. 51-91
    • Mobasheri, A.1    Avila, J.2    Cózar-Castellano, I.3
  • 10
    • 38349140152 scopus 로고    scopus 로고
    • Structures of the FXYD regulatory proteins in lipid micelles and membranes
    • Franzin CM, Gong XM, Teriete P, Marassi FM. Structures of the FXYD regulatory proteins in lipid micelles and membranes. J Bioenerg Biomembr 2007; 39: 379-383.
    • (2007) J Bioenerg Biomembr , vol.39 , pp. 379-383
    • Franzin, C.M.1    Gong, X.M.2    Teriete, P.3    Marassi, F.M.4
  • 11
    • 0035282170 scopus 로고    scopus 로고
    • Functional properties of Na, K-ATPase, and their structural implications, as detected with biophysical techniques
    • Apell HJ, Karlish SJ. Functional properties of Na, K-ATPase, and their structural implications, as detected with biophysical techniques. J Membr Biol 2001; 180: 1-9.
    • (2001) J Membr Biol , vol.180 , pp. 1-9
    • Apell, H.J.1    Karlish, S.J.2
  • 12
    • 33846783324 scopus 로고    scopus 로고
    • The Na, K-ATPase receptor complex: Its organization and membership
    • Pierre SV, Xie Z. The Na, K-ATPase receptor complex: its organization and membership. Cell Biochem Biophys 2006; 46: 303-16.
    • (2006) Cell Biochem Biophys , vol.46 , pp. 303-316
    • Pierre, S.V.1    Xie, Z.2
  • 13
    • 37249088547 scopus 로고    scopus 로고
    • Crystal structure of the sodium-potassium pump
    • Morth JP, Pedersen BP, Toustrup-Jensen MS, et al. Crystal structure of the sodium-potassium pump. Nature 2007; 450: 1043-9.
    • (2007) Nature , vol.450 , pp. 1043-1049
    • Morth, J.P.1    Pedersen, B.P.2    Toustrup-Jensen, M.S.3
  • 14
    • 79954415607 scopus 로고    scopus 로고
    • Structural insights into the high affinity binding of cardiotonic steroids to the Na+, K+-ATPase
    • Yatime L, Laursen M, Morth JP, et al. Structural insights into the high affinity binding of cardiotonic steroids to the Na+, K+-ATPase. J Struct Biol 2011; 174: 296-306.
    • (2011) J Struct Biol , vol.174 , pp. 296-306
    • Yatime, L.1    Laursen, M.2    Morth, J.P.3
  • 15
    • 84885654984 scopus 로고    scopus 로고
    • Crystal structure of a Na+-bound Na+, K+-ATPase preceding the E1P state
    • Kanai R, Ogawa H, Vilsen B, et al. Crystal structure of a Na+-bound Na+, K+-ATPase preceding the E1P state. Nature 2013; 502: 201-6.
    • (2013) Nature , vol.502 , pp. 201-206
    • Kanai, R.1    Ogawa, H.2    Vilsen, B.3
  • 16
    • 69549106325 scopus 로고    scopus 로고
    • Crystal structure of the sodium-potassium pump (Na+, K+-ATPase) with bound potassium and ouabain
    • Ogawa H, Shinoda T, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump (Na+, K+-ATPase) with bound potassium and ouabain. Proc Natl Acad Sci USA 2009; 106: 13742-7.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 13742-13747
    • Ogawa, H.1    Shinoda, T.2    Cornelius, F.3    Toyoshima, C.4
  • 17
    • 66249147196 scopus 로고    scopus 로고
    • Crystal structure of the sodium-potassium pump at 2. 4 A resolution
    • Shinoda T, Ogawa H, Cornelius F, Toyoshima C. Crystal structure of the sodium-potassium pump at 2. 4 A resolution. Nature 2009; 459: 446-50.
    • (2009) Nature , vol.459 , pp. 446-450
    • Shinoda, T.1    Ogawa, H.2    Cornelius, F.3    Toyoshima, C.4
  • 18
    • 0018088023 scopus 로고
    • Alteration of sodium transport in mouse mammary epithelium associated with neoplastic transformation
    • Shen SS, Hamamoto ST, Bern HA, Steinhardt RA. Alteration of sodium transport in mouse mammary epithelium associated with neoplastic transformation. Cancer Res 1978; 38: 1356-61.
    • (1978) Cancer Res , vol.38 , pp. 1356-1361
    • Shen, S.S.1    Hamamoto, S.T.2    Bern, H.A.3    Steinhardt, R.A.4
  • 19
    • 0022566579 scopus 로고
    • Properties of Na+/K+ ATPase and alkaline phosphatase alter during spontaneous and radiation-induced leukemogenesis in mice
    • Gonta-Grabiec K, Rossowski W, Szumiel I. Properties of Na+/K+ ATPase and alkaline phosphatase alter during spontaneous and radiation-induced leukemogenesis in mice. Neoplasma 1986; 33: 141-55.
    • (1986) Neoplasma , vol.33 , pp. 141-155
    • Gonta-Grabiec, K.1    Rossowski, W.2    Szumiel, I.3
  • 20
    • 0020025086 scopus 로고
    • Cardiac glycosides and breast cancer, revisited
    • Stenkvist B, Bengtsson E, Dahlqvist B, et al. Cardiac glycosides and breast cancer, revisited. N Engl J Med 1982; 306: 484.
    • (1982) N Engl J Med , vol.306 , pp. 484
    • Stenkvist, B.1    Bengtsson, E.2    Dahlqvist, B.3
  • 21
    • 68849107545 scopus 로고    scopus 로고
    • Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na, KATPase alpha subunits as drug targets
    • Yang P, Menter DG, Cartwright C, et al. Oleandrin-mediated inhibition of human tumor cell proliferation: importance of Na, KATPase alpha subunits as drug targets. Mol Cancer Ther 2009; 8: 2319-28.
    • (2009) Mol Cancer Ther , vol.8 , pp. 2319-2328
    • Yang, P.1    Menter, D.G.2    Cartwright, C.3
  • 22
    • 0034886564 scopus 로고    scopus 로고
    • Cardenolides and cancer
    • Stenkvist B. Cardenolides and cancer. Anticancer Drugs 2001; 12: 635-8.
    • (2001) Anticancer Drugs , vol.12 , pp. 635-638
    • Stenkvist, B.1
  • 23
    • 3042611499 scopus 로고    scopus 로고
    • Digitoxin medication and cancer; case control and internal dose-response studies
    • Haux J, Klepp O, Spigset O, Tretli S. Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer 2001; 1: 11.
    • (2001) BMC Cancer , vol.1 , pp. 11
    • Haux, J.1    Klepp, O.2    Spigset, O.3    Tretli, S.4
  • 24
    • 79959922456 scopus 로고    scopus 로고
    • A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment
    • Platz EA, Yegnasubramanian S, Liu JO, et al. A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov 2011; 1: 68-77.
    • (2011) Cancer Discov , vol.1 , pp. 68-77
    • Platz, E.A.1    Yegnasubramanian, S.2    Liu, J.O.3
  • 25
    • 84875067038 scopus 로고    scopus 로고
    • Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study
    • Niraula S, Pond G, De Wit R, et al. Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study. Can Urol Assoc J 2013; 7(1-2): E74-81.
    • (2013) Can Urol Assoc J , vol.7 , Issue.1-2 , pp. 74-81
    • Niraula, S.1    Pond, G.2    De Wit, R.3
  • 26
    • 84875067038 scopus 로고    scopus 로고
    • Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study
    • Niraula S, Pond G, de Wit R, et al. Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study. Can Urol Assoc J 2013; 7: E74-81.
    • (2013) Can Urol Assoc J , vol.7 , pp. 74-81
    • Niraula, S.1    Pond, G.2    de Wit, R.3
  • 27
    • 84864128654 scopus 로고    scopus 로고
    • Cardiac glycosides exert anticancer effects by inducing immunogenic cell death
    • 143ra199
    • Menger L, Vacchelli E, Adjemian S, et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med 2012; 4: 143ra199.
    • (2012) Sci Transl Med , vol.4
    • Menger, L.1    Vacchelli, E.2    Adjemian, S.3
  • 28
    • 63849286667 scopus 로고    scopus 로고
    • Digoxin treatment is associated with an increased incidence of breast cancer: A population-based case-control study
    • Ahern TP, Lash TL, Sørensen HT, Pedersen L. Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Res 2008; 10: R102.
    • (2008) Breast Cancer Res , vol.10
    • Ahern, T.P.1    Lash, T.L.2    Sørensen, H.T.3    Pedersen, L.4
  • 29
    • 79957962089 scopus 로고    scopus 로고
    • Digoxin use and the risk of breast cancer in women
    • Biggar RJ, Wohlfahrt J, Oudin A, et al. Digoxin use and the risk of breast cancer in women. J Clin Oncol 2011; 29: 2165-70.
    • (2011) J Clin Oncol , vol.29 , pp. 2165-2170
    • Biggar, R.J.1    Wohlfahrt, J.2    Oudin, A.3
  • 30
    • 84861577948 scopus 로고    scopus 로고
    • Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix
    • Biggar RJ, Wohlfahrt J, Melbye M. Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix. Int J Cancer 2012; 131: 716-21.
    • (2012) Int J Cancer , vol.131 , pp. 716-721
    • Biggar, R.J.1    Wohlfahrt, J.2    Melbye, M.3
  • 31
    • 0038380368 scopus 로고    scopus 로고
    • Multiplex gene expression analysis for high-throughput drug discovery: Screening and analysis of compounds affecting genes overexpressed in cancer cells
    • Johnson PH, Walker RP, Jones SW, et al. Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cells. Mol Cancer Ther 2002; 1: 1293-304.
    • (2002) Mol Cancer Ther , vol.1 , pp. 1293-1304
    • Johnson, P.H.1    Walker, R.P.2    Jones, S.W.3
  • 32
    • 58149374576 scopus 로고    scopus 로고
    • Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth
    • Zhang H, Qian DZ, Tan YS, et al. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci USA 2008; 105: 19579-86.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 19579-19586
    • Zhang, H.1    Qian, D.Z.2    Tan, Y.S.3
  • 33
    • 84863275539 scopus 로고    scopus 로고
    • Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: Opportunities for repurposing
    • Zhang L, He M, Zhang Y, et al. Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing. J Clin Endocrinol Metab 2012; 97: E319-328.
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 319-328
    • Zhang, L.1    He, M.2    Zhang, Y.3
  • 34
    • 0036670678 scopus 로고    scopus 로고
    • Selective cytotoxicity evaluation in anticancer drug screening of fractionated plant extracts
    • Lindholm P, Gullbo J, Claeson P, et al. Selective cytotoxicity evaluation in anticancer drug screening of fractionated plant extracts. J Biomol Screen 2002; 7: 333-40.
    • (2002) J Biomol Screen , vol.7 , pp. 333-340
    • Lindholm, P.1    Gullbo, J.2    Claeson, P.3
  • 35
    • 66149142810 scopus 로고    scopus 로고
    • Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation
    • Simpson CD, Mawji IA, Anyiwe K, et al. Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation. Cancer Res 2009; 69: 2739-47.
    • (2009) Cancer Res , vol.69 , pp. 2739-2747
    • Simpson, C.D.1    Mawji, I.A.2    Anyiwe, K.3
  • 37
    • 84862299900 scopus 로고    scopus 로고
    • Modulators of Na/K-ATPase: A patent review
    • Wang HY, O'Doherty GA. Modulators of Na/K-ATPase: a patent review. Expert Opin Ther Pat 2012; 22: 587-605.
    • (2012) Expert Opin Ther Pat , vol.22 , pp. 587-605
    • Wang, H.Y.1    O'Doherty, G.A.2
  • 38
    • 77953482802 scopus 로고    scopus 로고
    • Selectivity of digitalis glycosides for isoforms of human Na, K-ATPase
    • Katz A, Lifshitz Y, Bab-Dinitz E, et al. Selectivity of digitalis glycosides for isoforms of human Na, K-ATPase. J Biol Chem 2010; 285: 19582-92.
    • (2010) J Biol Chem , vol.285 , pp. 19582-19592
    • Katz, A.1    Lifshitz, Y.2    Bab-Dinitz, E.3
  • 39
    • 2342487353 scopus 로고    scopus 로고
    • Na+-K+-ATPase-mediated signal transduction: From protein interaction to cellular function
    • Xie Z, Cai T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv 2003; 3: 157-68.
    • (2003) Mol Interv , vol.3 , pp. 157-168
    • Xie, Z.1    Cai, T.2
  • 40
    • 84899493792 scopus 로고    scopus 로고
    • Digitalis-induced cell signaling by the sodium pump: On the relation of Src to Na(+)/K(+)-ATPase
    • Gable ME, Abdallah SL, Najjar SM, et al. Digitalis-induced cell signaling by the sodium pump: on the relation of Src to Na(+)/K(+)-ATPase. Biochem Biophys Res Commun 2014; 446: 1151-4.
    • (2014) Biochem Biophys Res Commun , vol.446 , pp. 1151-1154
    • Gable, M.E.1    Abdallah, S.L.2    Najjar, S.M.3
  • 41
    • 40849124038 scopus 로고    scopus 로고
    • Cardiac glycosides as novel cancer therapeutic agents
    • Newman RA, Yang P, Pawlus AD, Block KI. Cardiac glycosides as novel cancer therapeutic agents. Mol Interv 2008; 8: 36-49.
    • (2008) Mol Interv , vol.8 , pp. 36-49
    • Newman, R.A.1    Yang, P.2    Pawlus, A.D.3    Block, K.I.4
  • 42
    • 84874941459 scopus 로고    scopus 로고
    • Cardiotonic steroids-mediated Na+/K+-ATPase targeting could circumvent various chemoresistance pathways
    • Mijatovic T, Kiss R. Cardiotonic steroids-mediated Na+/K+-ATPase targeting could circumvent various chemoresistance pathways. Planta Med 2013; 79: 189-98.
    • (2013) Planta Med , vol.79 , pp. 189-198
    • Mijatovic, T.1    Kiss, R.2
  • 43
    • 0021808886 scopus 로고
    • Pharmacokinetics, bioavailability and serum levels of cardiac glycosides
    • Smith TW. Pharmacokinetics, bioavailability and serum levels of cardiac glycosides. J Am Coll Cardiol 1985; 5: 43A-50A.
    • (1985) J Am Coll Cardiol , vol.5 , pp. 43-50
    • Smith, T.W.1
  • 44
    • 16344369879 scopus 로고    scopus 로고
    • Digoxin inhibits neuroblastoma tumor growth in mice
    • Svensson A, Azarbayjani F, Bäckman U, et al. Digoxin inhibits neuroblastoma tumor growth in mice. Anticancer Res 2005; 25: 207-12.
    • (2005) Anticancer Res , vol.25 , pp. 207-212
    • Svensson, A.1    Azarbayjani, F.2    Bäckman, U.3
  • 45
    • 77949524121 scopus 로고    scopus 로고
    • Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis
    • Perne A, Muellner MK, Steinrueck M, et al. Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis. PLoS One 2009; 4: e8292.
    • (2009) PLoS One , vol.4
    • Perne, A.1    Muellner, M.K.2    Steinrueck, M.3
  • 46
    • 84904479799 scopus 로고    scopus 로고
    • Steroidal Cardiac Na+/K+ ATPase Inhibitors Exhibit Strong Anti-Cancer Potential in vitro and in Prostate and Lung Cancer Xenografts in vivo
    • Dimas K, Papadopoulou N, Baskakis C, et al. Steroidal Cardiac Na+/K+ ATPase Inhibitors Exhibit Strong Anti-Cancer Potential in vitro and in Prostate and Lung Cancer Xenografts in vivo. Anticancer Agents Med Chem 2014; 14(5): 762-70.
    • (2014) Anticancer Agents Med Chem , vol.14 , Issue.5 , pp. 762-770
    • Dimas, K.1    Papadopoulou, N.2    Baskakis, C.3
  • 49
    • 81055149905 scopus 로고    scopus 로고
    • Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks
    • Prassas I, Karagiannis GS, Batruch I, et al. Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks. Mol Cancer Ther 2011; 10: 2083-93.
    • (2011) Mol Cancer Ther , vol.10 , pp. 2083-2093
    • Prassas, I.1    Karagiannis, G.S.2    Batruch, I.3
  • 50
    • 34547754022 scopus 로고    scopus 로고
    • Digitoxin as an anticancer agent with selectivity for cancer cells: Possible mechanisms involved
    • López-Lázaro M. Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved. Expert Opin Ther Targets 2007; 11: 1043-53.
    • (2007) Expert Opin Ther Targets , vol.11 , pp. 1043-1053
    • López-Lázaro, M.1
  • 51
    • 84864648362 scopus 로고    scopus 로고
    • Digitoxin and its analogs as novel cancer therapeutics
    • Elbaz HA, Stueckle TA, Tse W, et al. Digitoxin and its analogs as novel cancer therapeutics. Exp Hematol Oncol 2012; 1: 4.
    • (2012) Exp Hematol Oncol , vol.1 , pp. 4
    • Elbaz, H.A.1    Stueckle, T.A.2    Tse, W.3
  • 52
    • 33646699335 scopus 로고    scopus 로고
    • Oleandrin-mediated oxidative stress in human melanoma cells
    • Newman RA, Yang P, Hittelman WN, et al. Oleandrin-mediated oxidative stress in human melanoma cells. J Exp Ther Oncol 2006; 5: 167-81.
    • (2006) J Exp Ther Oncol , vol.5 , pp. 167-181
    • Newman, R.A.1    Yang, P.2    Hittelman, W.N.3
  • 53
    • 0034660878 scopus 로고    scopus 로고
    • Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells
    • McConkey DJ, Lin Y, Nutt LK, et al. Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res 2000; 60: 3807-12.
    • (2000) Cancer Res , vol.60 , pp. 3807-3812
    • McConkey, D.J.1    Lin, Y.2    Nutt, L.K.3
  • 54
    • 33846470475 scopus 로고    scopus 로고
    • Cardiac glycoside induces cell death via FasL by activating calcineurin and NF-AT, but apoptosis initially proceeds through activation of caspases
    • Raghavendra PB, Sreenivasan Y, Ramesh GT, Manna SK. Cardiac glycoside induces cell death via FasL by activating calcineurin and NF-AT, but apoptosis initially proceeds through activation of caspases. Apoptosis 2007; 12: 307-18.
    • (2007) Apoptosis , vol.12 , pp. 307-318
    • Raghavendra, P.B.1    Sreenivasan, Y.2    Ramesh, G.T.3    Manna, S.K.4
  • 55
    • 33846188582 scopus 로고    scopus 로고
    • Oleandrin induces apoptosis in human, but not in murine cells: Dephosphorylation of Akt, expression of FasL, and alteration of membrane fluidity
    • Raghavendra PB, Sreenivasan Y, Manna SK. Oleandrin induces apoptosis in human, but not in murine cells: dephosphorylation of Akt, expression of FasL, and alteration of membrane fluidity. Mol Immunol 2007; 44: 2292-302.
    • (2007) Mol Immunol , vol.44 , pp. 2292-2302
    • Raghavendra, P.B.1    Sreenivasan, Y.2    Manna, S.K.3
  • 56
    • 36249023658 scopus 로고    scopus 로고
    • Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipidsoluble cardiac glycoside
    • Newman RA, Kondo Y, Yokoyama T, et al. Autophagic cell death of human pancreatic tumor cells mediated by oleandrin, a lipidsoluble cardiac glycoside. Integr Cancer Ther 2007; 6: 354-64.
    • (2007) Integr Cancer Ther , vol.6 , pp. 354-364
    • Newman, R.A.1    Kondo, Y.2    Yokoyama, T.3
  • 57
    • 33745013348 scopus 로고    scopus 로고
    • Phase 1 trial of Anvirzel in patients with refractory solid tumors
    • Mekhail T, Kaur H, Ganapathi R, et al. Phase 1 trial of Anvirzel in patients with refractory solid tumors. Invest New Drugs 2006; 24: 423-27.
    • (2006) Invest New Drugs , vol.24 , pp. 423-427
    • Mekhail, T.1    Kaur, H.2    Ganapathi, R.3
  • 58
    • 84938690353 scopus 로고    scopus 로고
    • First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-β and p70s6k, in patients with advanced solid tumors
    • [Epub ahead of print]
    • Hong DS, Henary H, Falchook GS, et al. First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-β and p70s6k, in patients with advanced solid tumors. Invest New Drugs 2014 [Epub ahead of print].
    • (2014) Invest New Drugs
    • Hong, D.S.1    Henary, H.2    Falchook, G.S.3
  • 59
    • 33644974357 scopus 로고    scopus 로고
    • The cardenolide UNBS1450 is able to deactivate nuclear factor kappaBmediated cytoprotective effects in human non-small cell lung cancer cells
    • Mijatovic T, Op De Beeck A, Van Quaquebeke E, et al. The cardenolide UNBS1450 is able to deactivate nuclear factor kappaBmediated cytoprotective effects in human non-small cell lung cancer cells. Mol Cancer Ther 2006; 5: 391-9.
    • (2006) Mol Cancer Ther , vol.5 , pp. 391-399
    • Mijatovic, T.1    Op De Beeck, A.2    Van Quaquebeke, E.3
  • 60
    • 20044369153 scopus 로고    scopus 로고
    • Identification of a novel cardenolide (2''-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: Structure-activity relationship analyses
    • Van Quaquebeke E, Simon G, André A, et al. Identification of a novel cardenolide (2''-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: structure-activity relationship analyses. J Med Chem 2005; 48: 849-56.
    • (2005) J Med Chem , vol.48 , pp. 849-856
    • Van Quaquebeke, E.1    Simon, G.2    André, A.3
  • 61
    • 34249825771 scopus 로고    scopus 로고
    • The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers
    • Mijatovic T, Roland I, Van Quaquebeke E, et al. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J Pathol 2007; 212: 170-9.
    • (2007) J Pathol , vol.212 , pp. 170-179
    • Mijatovic, T.1    Roland, I.2    Van Quaquebeke, E.3
  • 62
    • 41749099092 scopus 로고    scopus 로고
    • Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells
    • discussion 221-12
    • Lefranc F, Mijatovic T, Kondo Y, et al. Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells. Neurosurgery 2008; 62: 211-21; discussion 221-12.
    • (2008) Neurosurgery , vol.62 , pp. 211-221
    • Lefranc, F.1    Mijatovic, T.2    Kondo, Y.3
  • 63
    • 70350080771 scopus 로고    scopus 로고
    • The sodium pump alpha1 sub-unit: A disease progression-related target for metastatic melanoma treatment
    • Mathieu V, Pirker C, Martin de Lassalle E, et al. The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment. J Cell Mol Med 2009; 13: 3960-72.
    • (2009) J Cell Mol Med , vol.13 , pp. 3960-3972
    • Mathieu, V.1    Pirker, C.2    Martin de Lassalle, E.3
  • 64
    • 49849100632 scopus 로고    scopus 로고
    • Nucleolus and c-Myc: Potential targets of cardenolide-mediated antitumor activity
    • Mijatovic T, De Nève N, Gailly P, et al. Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity. Mol Cancer Ther 2008; 7: 1285-96.
    • (2008) Mol Cancer Ther , vol.7 , pp. 1285-1296
    • Mijatovic, T.1    De Nève, N.2    Gailly, P.3
  • 65
    • 33744824903 scopus 로고    scopus 로고
    • Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers
    • Mijatovic T, Mathieu V, Gaussin JF, et al. Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 2006; 8: 402-12.
    • (2006) Neoplasia , vol.8 , pp. 402-412
    • Mijatovic, T.1    Mathieu, V.2    Gaussin, J.F.3
  • 66
    • 78549284246 scopus 로고    scopus 로고
    • UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells
    • Juncker T, Cerella C, Teiten MH, et al. UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells. Biochem Pharmacol 2011; 81: 13-23.
    • (2011) Biochem Pharmacol , vol.81 , pp. 13-23
    • Juncker, T.1    Cerella, C.2    Teiten, M.H.3
  • 67
    • 24744443929 scopus 로고    scopus 로고
    • Induction of apoptosis by Chan Su, a traditional Chinese medicine, in human bladder carcinoma T24 cells
    • Ko WS, Park TY, Park C, et al. Induction of apoptosis by Chan Su, a traditional Chinese medicine, in human bladder carcinoma T24 cells. Oncol Rep 2005; 14: 475-80.
    • (2005) Oncol Rep , vol.14 , pp. 475-480
    • Ko, W.S.1    Park, T.Y.2    Park, C.3
  • 68
    • 84902974693 scopus 로고    scopus 로고
    • Bufalin inhibited the growth of human osteosarcoma MG-63 cells via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway
    • Wang D, Bi Z. Bufalin inhibited the growth of human osteosarcoma MG-63 cells via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway. Tumour Biol 2014; 35: 4885-90.
    • (2014) Tumour Biol , vol.35 , pp. 4885-4890
    • Wang, D.1    Bi, Z.2
  • 69
    • 84901616419 scopus 로고    scopus 로고
    • Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells
    • Yan S, Qu X, Xu L, et al. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells. Anticancer Drugs 2014; 25: 683-9.
    • (2014) Anticancer Drugs , vol.25 , pp. 683-689
    • Yan, S.1    Qu, X.2    Xu, L.3
  • 70
    • 84896517086 scopus 로고    scopus 로고
    • Bufalin is a potent smallmolecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1
    • Wang Y, Lonard DM, Yu Y, et al. Bufalin is a potent smallmolecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res 2014; 74: 1506-17.
    • (2014) Cancer Res , vol.74 , pp. 1506-1517
    • Wang, Y.1    Lonard, D.M.2    Yu, Y.3
  • 71
    • 84896721859 scopus 로고    scopus 로고
    • Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress
    • Shen S, Zhang Y, Wang Z, et al. Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress. Int J Biol Sci 2014; 10: 212-24.
    • (2014) Int J Biol Sci , vol.10 , pp. 212-224
    • Shen, S.1    Zhang, Y.2    Wang, Z.3
  • 72
    • 58149229785 scopus 로고    scopus 로고
    • Efficacy and safety of gemcitabineoxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma
    • Qin TJ, Zhao XH, Yun J, et al. Efficacy and safety of gemcitabineoxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma. World J Gastroenterol 2008; 14: 5210-6.
    • (2008) World J Gastroenterol , vol.14 , pp. 5210-5216
    • Qin, T.J.1    Zhao, X.H.2    Yun, J.3
  • 73
    • 70449376872 scopus 로고    scopus 로고
    • Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer
    • Meng Z, Yang P, Shen Y, et al. Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer 2009; 115: 5309-18.
    • (2009) Cancer , vol.115 , pp. 5309-5318
    • Meng, Z.1    Yang, P.2    Shen, Y.3
  • 74
    • 84864377344 scopus 로고    scopus 로고
    • Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: A randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas
    • Meng Z, Garrett CR, Shen Y, et al. Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas. Br J Cancer 2012; 107: 411-6.
    • (2012) Br J Cancer , vol.107 , pp. 411-416
    • Meng, Z.1    Garrett, C.R.2    Shen, Y.3
  • 75
    • 0042732944 scopus 로고    scopus 로고
    • Structure-based design and synthesis of novel potent Na+, K+-ATPase inhibitors derived from a 5alpha, 14alpha-androstane scaffold as positive inotropic compounds
    • De Munari S, Cerri A, Gobbini M, et al. Structure-based design and synthesis of novel potent Na+, K+-ATPase inhibitors derived from a 5alpha, 14alpha-androstane scaffold as positive inotropic compounds. J Med Chem 2003; 46: 3644-54.
    • (2003) J Med Chem , vol.46 , pp. 3644-3654
    • De Munari, S.1    Cerri, A.2    Gobbini, M.3
  • 76
    • 49449108728 scopus 로고    scopus 로고
    • Novel analogues of istaroxime, a potent inhibitor of Na+, K+-ATPase: Synthesis and structure-activity relationship
    • Gobbini M, Armaroli S, Banfi L, et al. Novel analogues of istaroxime, a potent inhibitor of Na+, K+-ATPase: synthesis and structure-activity relationship. J Med Chem 2008; 51: 4601-8.
    • (2008) J Med Chem , vol.51 , pp. 4601-4608
    • Gobbini, M.1    Armaroli, S.2    Banfi, L.3
  • 77
    • 77953139706 scopus 로고    scopus 로고
    • Novel analogues of Istaroxime, a potent inhibitor of Na(+), K(+)-ATPase: Synthesis, structure-activity relationship and 3D-quantitative structure-activity relationship of derivatives at position 6 on the androstane scaffold
    • Gobbini M, Armaroli S, Banfi L, et al. Novel analogues of Istaroxime, a potent inhibitor of Na(+), K(+)-ATPase: Synthesis, structure-activity relationship and 3D-quantitative structure-activity relationship of derivatives at position 6 on the androstane scaffold. Bioorg Med Chem 2010; 18: 4275-99.
    • (2010) Bioorg Med Chem , vol.18 , pp. 4275-4299
    • Gobbini, M.1    Armaroli, S.2    Banfi, L.3
  • 78
    • 0036827948 scopus 로고    scopus 로고
    • Pharmacological profile of the novel inotropic agent (E, Z)-3-((2-aminoethoxy)imino)androstane-6, 17-dione hydrochloride (PST2744)
    • Micheletti R, Mattera GG, Rocchetti M, et al. Pharmacological profile of the novel inotropic agent (E, Z)-3-((2-aminoethoxy)imino)androstane-6, 17-dione hydrochloride (PST2744). J Pharmacol Exp Ther 2002; 303: 592-600.
    • (2002) J Pharmacol Exp Ther , vol.303 , pp. 592-600
    • Micheletti, R.1    Mattera, G.G.2    Rocchetti, M.3
  • 79
    • 70449090165 scopus 로고    scopus 로고
    • Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: A new promising treatment for acute heart failure syndromes?
    • Khan H, Metra M, Blair JE, et al. Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes? Heart Fail Rev 2009; 14: 277-87.
    • (2009) Heart Fail Rev , vol.14 , pp. 277-287
    • Khan, H.1    Metra, M.2    Blair, J.E.3
  • 80
    • 44449084777 scopus 로고    scopus 로고
    • Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: A randomized controlled trial in patients hospitalized with heart failure
    • Gheorghiade M, Blair JE, Filippatos GS, et al. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol 2008; 51: 2276-85.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 2276-2285
    • Gheorghiade, M.1    Blair, J.E.2    Filippatos, G.S.3
  • 81
    • 67049100043 scopus 로고    scopus 로고
    • Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: Results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: A Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial
    • Shah SJ, Blair JE, Filippatos GS, et al. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J 2009; 157: 1035-41.
    • (2009) Am Heart J , vol.157 , pp. 1035-1041
    • Shah, S.J.1    Blair, J.E.2    Filippatos, G.S.3
  • 82
    • 0018375632 scopus 로고
    • Digoxin and hormone receptors
    • Cove DH, Barker GA. Digoxin and hormone receptors. Lancet 1979; 2: 204.
    • (1979) Lancet , vol.2 , pp. 204
    • Cove, D.H.1    Barker, G.A.2
  • 83
    • 84906319891 scopus 로고    scopus 로고
    • The Steroidal Na+/K+ ATPase Inhibitor 3-[(R)-3-Pyrrolidinyl]oxime Derivative (3-R-POD) Induces Potent Pro-Apoptotic Responses in Colonic Tumor Cells
    • Alkahtani SH. The Steroidal Na+/K+ ATPase Inhibitor 3-[(R)-3-Pyrrolidinyl]oxime Derivative (3-R-POD) Induces Potent Pro-Apoptotic Responses in Colonic Tumor Cells. Anticancer Res 2014; 34: 2967-71.
    • (2014) Anticancer Res , vol.34 , pp. 2967-2971
    • Alkahtani, S.H.1
  • 84
    • 84907175981 scopus 로고    scopus 로고
    • A steroidal Na+/K+ ATPase Inhibitor Triggers Pro-Apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells
    • [Epub ahead of print]
    • Honisch S, Alkahtani S, Kounenidakis M, et al. A steroidal Na+/K+ ATPase Inhibitor Triggers Pro-Apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells. Anticancer Agents Med Chem 2014 [Epub ahead of print].
    • (2014) Anticancer Agents Med Chem
    • Honisch, S.1    Alkahtani, S.2    Kounenidakis, M.3
  • 85
    • 84869783143 scopus 로고    scopus 로고
    • Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCβ without inhibiting Akt
    • Sarveswaran S, Gautam SC, Ghosh J. Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCβ without inhibiting Akt. Int J Oncol 2012; 41: 2191-9.
    • (2012) Int J Oncol , vol.41 , pp. 2191-2199
    • Sarveswaran, S.1    Gautam, S.C.2    Ghosh, J.3
  • 86
    • 84877909949 scopus 로고    scopus 로고
    • Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation
    • Chen Z, Sun X, Shen S, et al. Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation. J Biol Chem 2013; 288: 14417-27.
    • (2013) J Biol Chem , vol.288 , pp. 14417-14427
    • Chen, Z.1    Sun, X.2    Shen, S.3
  • 87
    • 77952404297 scopus 로고    scopus 로고
    • Identification of hydroxyxanthones as Na/K-ATPase ligands
    • Zhang Z, Li Z, Tian J, et al. Identification of hydroxyxanthones as Na/K-ATPase ligands. Mol Pharmacol 2010; 77: 961-7.
    • (2010) Mol Pharmacol , vol.77 , pp. 961-967
    • Zhang, Z.1    Li, Z.2    Tian, J.3
  • 88
    • 84921990756 scopus 로고    scopus 로고
    • Gossypol enhances radiation induced autophagy in glioblastoma multiforme
    • [Epub ahead of print]
    • Keshmiri-Neghab H, Goliaei B, Nikoofar A. Gossypol enhances radiation induced autophagy in glioblastoma multiforme. Gen Physiol Biophys 2014 [Epub ahead of print].
    • (2014) Gen Physiol Biophys
    • Keshmiri-Neghab, H.1    Goliaei, B.2    Nikoofar, A.3
  • 89
    • 84902210311 scopus 로고    scopus 로고
    • Gossypol Increases Expression of the Pro-apoptotic BH3-only Protein NOXA through a Novel Mechanism Involving Phospholipase A2, Cytoplasmic Calcium, and Endoplasmic Reticulum Stress
    • Soderquist RS, Danilov AV, Eastman A. Gossypol Increases Expression of the Pro-apoptotic BH3-only Protein NOXA through a Novel Mechanism Involving Phospholipase A2, Cytoplasmic Calcium, and Endoplasmic Reticulum Stress. J Biol Chem 2014; 289: 16190-16199.
    • (2014) J Biol Chem , vol.289 , pp. 16190-16199
    • Soderquist, R.S.1    Danilov, A.V.2    Eastman, A.3
  • 90
    • 84901188207 scopus 로고    scopus 로고
    • Glucocorticoid sensitisation in Mixed Lineage Leukaemiarearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101
    • Spijkers-Hagelstein JA, Schneider P, Pinhanços SM, et al. Glucocorticoid sensitisation in Mixed Lineage Leukaemiarearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101. Eur J Cancer 2014; 50: 1665-74.
    • (2014) Eur J Cancer , vol.50 , pp. 1665-1674
    • Spijkers-Hagelstein, J.A.1    Schneider, P.2    Pinhanços, S.M.3
  • 91
    • 84898474749 scopus 로고    scopus 로고
    • BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cipα.)
    • Jang GH, Lee M. BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cipα.. Life Sci 2014; 102: 41-48.
    • (2014) Life Sci , vol.102 , pp. 41-48
    • Jang, G.H.1    Lee, M.2
  • 92
    • 84890502480 scopus 로고    scopus 로고
    • Therapeutic potential of gossypol: An overview
    • Keshmiri-Neghab H, Goliaei B. Therapeutic potential of gossypol: an overview. Pharm Biol 2014; 52: 124-8.
    • (2014) Pharm Biol , vol.52 , pp. 124-128
    • Keshmiri-Neghab, H.1    Goliaei, B.2
  • 93
    • 84863981435 scopus 로고    scopus 로고
    • Evidence for a potential tumor suppressor role for the Na, K-ATPase beta1-subunit
    • Inge LJ, Rajasekaran SA, Yoshimoto K, et al. Evidence for a potential tumor suppressor role for the Na, K-ATPase beta1-subunit. Histol Histopathol 2008; 23: 459-67.
    • (2008) Histol Histopathol , vol.23 , pp. 459-467
    • Inge, L.J.1    Rajasekaran, S.A.2    Yoshimoto, K.3
  • 94
    • 84872746243 scopus 로고    scopus 로고
    • "The Lower Threshold" phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis?
    • Weidemann H. "The Lower Threshold" phenomenon in tumor cells toward endogenous digitalis-like compounds: Responsible for tumorigenesis? J Carcinog 2012; 11: 2.
    • (2012) J Carcinog , vol.11 , pp. 2
    • Weidemann, H.1
  • 95
    • 84867772337 scopus 로고    scopus 로고
    • Characterization of humaninduced pluripotent stem cell-derived cardiomyocytes: Bioenergetics and utilization in safety screening
    • Rana P, Anson B, Engle S, Will Y. Characterization of humaninduced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. Toxicol Sci 2012; 130: 117-131.
    • (2012) Toxicol Sci , vol.130 , pp. 117-131
    • Rana, P.1    Anson, B.2    Engle, S.3    Will, Y.4
  • 96
    • 0037446091 scopus 로고    scopus 로고
    • Analysis of the Na, K-ATPase alpha-and beta-subunit expression profiles of bladder cancer using tissue microarrays
    • Espineda C, Seligson DB, James Ball W, et al. Analysis of the Na, K-ATPase alpha-and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer 2003; 97: 1859-1868.
    • (2003) Cancer , vol.97 , pp. 1859-1868
    • Espineda, C.1    Seligson, D.B.2    James Ball, W.3
  • 98
    • 0032885002 scopus 로고    scopus 로고
    • Regulation of expression of Na+, K+-ATPase in androgen-dependent and androgen-independent prostate cancer
    • Blok LJ, Chang GT, Steenbeek-Slotboom M, et al. Regulation of expression of Na+, K+-ATPase in androgen-dependent and androgen-independent prostate cancer. Br J Cancer 1999; 81: 28-36.
    • (1999) Br J Cancer , vol.81 , pp. 28-36
    • Blok, L.J.1    Chang, G.T.2    Steenbeek-Slotboom, M.3
  • 99
    • 0032866353 scopus 로고    scopus 로고
    • Reduced expression of beta-subunit of Na, K-ATPase in human clear-cell renal cell carcinoma
    • Rajasekaran SA, Ball WJ, Bander NH, et al. Reduced expression of beta-subunit of Na, K-ATPase in human clear-cell renal cell carcinoma. J Urol 1999; 162: 574-580.
    • (1999) J Urol , vol.162 , pp. 574-580
    • Rajasekaran, S.A.1    Ball, W.J.2    Bander, N.H.3
  • 100
    • 9244251969 scopus 로고    scopus 로고
    • Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization
    • Boukerche H, Su ZZ, Kang DC, Fisher PB. Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization. Gene 2004; 343: 191-201.
    • (2004) Gene , vol.343 , pp. 191-201
    • Boukerche, H.1    Su, Z.Z.2    Kang, D.C.3    Fisher, P.B.4
  • 101
    • 1542373736 scopus 로고    scopus 로고
    • Repression of Na, KATPase beta1-subunit by the transcription factor snail in carcinoma
    • Espineda CE, Chang JH, Twiss J, et al. Repression of Na, KATPase beta1-subunit by the transcription factor snail in carcinoma. Mol Biol Cell 2004; 15: 1364-73.
    • (2004) Mol Biol Cell , vol.15 , pp. 1364-1373
    • Espineda, C.E.1    Chang, J.H.2    Twiss, J.3
  • 102
    • 1842737653 scopus 로고    scopus 로고
    • Up-regulation of Na(+), K(+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer
    • Sakai H, Suzuki T, Maeda M, et al. Up-regulation of Na(+), K(+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer. FEBS Lett 2004; 563: 151-4.
    • (2004) FEBS Lett , vol.563 , pp. 151-154
    • Sakai, H.1    Suzuki, T.2    Maeda, M.3
  • 103
    • 36749015141 scopus 로고    scopus 로고
    • Na, K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma
    • Seligson DB, Rajasekaran SA, Yu H, et al. Na, K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma. J Urol 2008; 179: 338-45.
    • (2008) J Urol , vol.179 , pp. 338-345
    • Seligson, D.B.1    Rajasekaran, S.A.2    Yu, H.3
  • 104
    • 79956070393 scopus 로고    scopus 로고
    • Immunohistochemical analyses of alpha1 and alpha3 Na+/K+-ATPase subunit expression in medulloblastomas
    • Suñol M, Cusi V, Cruz O, et al. Immunohistochemical analyses of alpha1 and alpha3 Na+/K+-ATPase subunit expression in medulloblastomas. Anticancer Res 2011; 31: 953-8.
    • (2011) Anticancer Res , vol.31 , pp. 953-958
    • Suñol, M.1    Cusi, V.2    Cruz, O.3
  • 105
    • 0028063457 scopus 로고
    • Neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors
    • Morrison BW, Leder P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994; 9: 3417-26.
    • (1994) Oncogene , vol.9 , pp. 3417-3426
    • Morrison, B.W.1    Leder, P.2
  • 106
    • 0034662757 scopus 로고    scopus 로고
    • The FXYD gene family of small ion transport regulators or channels: CDNA sequence, protein signature sequence, and expression
    • Sweadner KJ, Rael E. The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 2000; 68: 41-56.
    • (2000) Genomics , vol.68 , pp. 41-56
    • Sweadner, K.J.1    Rael, E.2
  • 107
    • 0033899865 scopus 로고    scopus 로고
    • Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression
    • Vaarala MH, Porvari K, Kyllönen A, Vihko P. Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression. Lab Invest 2000; 80: 1259-68.
    • (2000) Lab Invest , vol.80 , pp. 1259-1268
    • Vaarala, M.H.1    Porvari, K.2    Kyllönen, A.3    Vihko, P.4
  • 108
    • 3843134200 scopus 로고    scopus 로고
    • Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells
    • Grzmil M, Voigt S, Thelen P, et al. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Int J Oncol 2004; 24: 97-105.
    • (2004) Int J Oncol , vol.24 , pp. 97-105
    • Grzmil, M.1    Voigt, S.2    Thelen, P.3
  • 109
    • 27944509575 scopus 로고    scopus 로고
    • FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth
    • Kayed H, Kleeff J, Kolb A, et al. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth. Int J Cancer 2006; 118: 43-54.
    • (2006) Int J Cancer , vol.118 , pp. 43-54
    • Kayed, H.1    Kleeff, J.2    Kolb, A.3
  • 110
    • 73549112431 scopus 로고    scopus 로고
    • Down-regulation of FXYD3 expression in human lung cancers: Its mechanism and potential role in carcinogenesis
    • Okudela K, Yazawa T, Ishii J, et al. Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis. Am J Pathol 2009; 175: 2646-56.
    • (2009) Am J Pathol , vol.175 , pp. 2646-2656
    • Okudela, K.1    Yazawa, T.2    Ishii, J.3
  • 111
    • 77954037634 scopus 로고    scopus 로고
    • Expression and significance of FXYD-3 protein in gastric adenocarcinoma
    • Zhu ZL, Zhao ZR, Zhang Y, et al. Expression and significance of FXYD-3 protein in gastric adenocarcinoma. Dis Markers 2010; 28: 63-9.
    • (2010) Dis Markers , vol.28 , pp. 63-69
    • Zhu, Z.L.1    Zhao, Z.R.2    Zhang, Y.3
  • 112
    • 79952925205 scopus 로고    scopus 로고
    • FXYD3: A Promising Biomarker for Urothelial Carcinoma
    • Zhang Z, Pang ST, Kasper KA, et al. FXYD3: A Promising Biomarker for Urothelial Carcinoma. Biomark Insights 2011; 6: 17-26.
    • (2011) Biomark Insights , vol.6 , pp. 17-26
    • Zhang, Z.1    Pang, S.T.2    Kasper, K.A.3
  • 113
    • 0037441643 scopus 로고    scopus 로고
    • Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: Relationship to e-cadherin expression
    • Shimamura T, Sakamoto M, Ino Y, et al. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to e-cadherin expression. J Clin Oncol 2003; 21: 659-67.
    • (2003) J Clin Oncol , vol.21 , pp. 659-667
    • Shimamura, T.1    Sakamoto, M.2    Ino, Y.3
  • 114
    • 0037430034 scopus 로고    scopus 로고
    • Prognostic significance of dysadherin expression in advanced colorectal carcinoma
    • Aoki S, Shimamura T, Shibata T, et al. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br J Cancer 2003; 88: 726-32.
    • (2003) Br J Cancer , vol.88 , pp. 726-732
    • Aoki, S.1    Shimamura, T.2    Shibata, T.3
  • 115
    • 0141787918 scopus 로고    scopus 로고
    • Dysadherin: Expression and clinical significance in thyroid carcinoma
    • Sato H, Ino Y, Miura A, et al. Dysadherin: expression and clinical significance in thyroid carcinoma. J Clin Endocrinol Metab 2003; 88: 4407-12.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 4407-4412
    • Sato, H.1    Ino, Y.2    Miura, A.3
  • 116
    • 33645218212 scopus 로고    scopus 로고
    • Dysadherin expression in head and neck squamous cell carcinoma: Association with lymphangiogenesis and prognostic significance
    • Kyzas PA, Stefanou D, Batistatou A, et al. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol 2006; 30: 185-93.
    • (2006) Am J Surg Pathol , vol.30 , pp. 185-193
    • Kyzas, P.A.1    Stefanou, D.2    Batistatou, A.3
  • 117
    • 79952987885 scopus 로고    scopus 로고
    • Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion
    • Maehata Y, Hirahashi M, Aishima S, et al. Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion. Hum Pathol 2011; 42: 558-67.
    • (2011) Hum Pathol , vol.42 , pp. 558-567
    • Maehata, Y.1    Hirahashi, M.2    Aishima, S.3
  • 118
    • 79952032469 scopus 로고    scopus 로고
    • Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites
    • Mitselou A, Batistatou A, Nakanishi Y, et al. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites. Histol Histopathol 2010; 25: 1257-67.
    • (2010) Histol Histopathol , vol.25 , pp. 1257-1267
    • Mitselou, A.1    Batistatou, A.2    Nakanishi, Y.3
  • 119
    • 80054976328 scopus 로고    scopus 로고
    • A monoclonal antibody against human FXYD6
    • Liu J, Zhou N, Zhang X. A monoclonal antibody against human FXYD6. Hybridoma (Larchmt) 2011; 30: 487-90.
    • (2011) Hybridoma (Larchmt) , vol.30 , pp. 487-490
    • Liu, J.1    Zhou, N.2    Zhang, X.3
  • 120
    • 84890341993 scopus 로고    scopus 로고
    • FXYD6 is a new biomarker of cholangiocarcinoma
    • Chen X, Sun M, Hu Y, et al. FXYD6 is a new biomarker of cholangiocarcinoma. Oncol Lett 2014; 7: 393-8.
    • (2014) Oncol Lett , vol.7 , pp. 393-398
    • Chen, X.1    Sun, M.2    Hu, Y.3
  • 121
    • 84904196645 scopus 로고    scopus 로고
    • FXYD6: A novel therapeutic target toward hepatocellular carcinoma
    • Gao Q, Chen X, Duan H, et al. FXYD6: a novel therapeutic target toward hepatocellular carcinoma. Protein Cell 2014; 5: 532-43.
    • (2014) Protein Cell , vol.5 , pp. 532-543
    • Gao, Q.1    Chen, X.2    Duan, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.